+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alkermes plc - logo

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

From
From
From
From
Antipsychotic Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Antipsychotic Drugs Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 142 Pages
  • Global
From
Treatment Resistant Depression - Global Strategic Business Report - Product Thumbnail Image

Treatment Resistant Depression - Global Strategic Business Report

  • Report
  • September 2025
  • 277 Pages
  • Global
From
Depression Drugs - Global Strategic Business Report - Product Thumbnail Image

Depression Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
From
Drug Overview: Invega Sustenna/Invega Trinza - Product Thumbnail Image

Drug Overview: Invega Sustenna/Invega Trinza

  • Report
  • March 2018
  • 20 Pages
  • Global
From
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 950 Pages
  • Global
From
Loading Indicator